Cargando…

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome

PURPOSE: The benefit from attenuation and scatter correction (ASC) of dopamine transporter (DAT)-SPECT for the detection of nigrostriatal degeneration in clinical routine is still a matter of debate. The current study evaluated the impact of ASC on visual interpretation and semi-quantitative analysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiebler, Tassilo, Apostolova, Ivayla, Mathies, Franziska Lara, Lange, Catharina, Klutmann, Susanne, Buchert, Ralph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541531/ https://www.ncbi.nlm.nih.gov/pubmed/37328621 http://dx.doi.org/10.1007/s00259-023-06293-2

Ejemplares similares

Stereotactical normalization with multiple templates representative of normal and Parkinson-typical reduction of striatal uptake improves the discriminative power of automatic semi-quantitative analysis in dopamine transporter SPECT
por: Apostolova, Ivayla, et al.
Publicado: (2023)

Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
por: Nazari, Mahmood, et al.
Publicado: (2021)

Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
por: Schmitz-Steinkrüger, Helen, et al.
Publicado: (2020)

Multiple-pinhole collimators improve intra- and between-rater agreement and the certainty of the visual interpretation in dopamine transporter SPECT
por: Mathies, Franziska, et al.
Publicado: (2022)

Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT
por: Schmitz-Steinkrüger, Helen, et al.
Publicado: (2020)

Data-driven identification of diagnostically useful extrastriatal signal in dopamine transporter SPECT using explainable AI
por: Nazari, Mahmood, et al.
Publicado: (2021)

Diagnostic performance of the specific uptake size index for semi-quantitative analysis of I-123-FP-CIT SPECT: harmonized multi-center research setting versus typical clinical single-camera setting
por: Buchert, Ralph, et al.
Publicado: (2019)

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders
por: AKDEMİR, Ümit Özgür, et al.
Publicado: (2021)

Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
por: Jakobson Mo, Susanna, et al.
Publicado: (2013)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017)

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Evaluation of [(68) Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria
por: Koehler, Daniel, et al.
Publicado: (2022)

Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
por: Thiele, Felix, et al.
Publicado: (2023)

CT-Based Attenuation Correction in I-123-Ioflupane SPECT
por: Lange, Catharina, et al.
Publicado: (2014)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes
por: Vlaar, Annemarie MM, et al.
Publicado: (2007)

Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes
por: Shin, Dong Hoon, et al.
Publicado: (2006)

Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys
por: Gagnon, Dave, et al.
Publicado: (2018)

Comparison of [(18)F]-FDOPA PET and [(123)I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome
por: Wallert, Elon, et al.
Publicado: (2022)

Diagnostic accuracy of (18)F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
por: Oh, Minyoung, et al.
Publicado: (2023)

Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
por: Indrieri, Alessia, et al.
Publicado: (2020)

Review: Subjective Time Perception, Dopamine Signaling, and Parkinsonian Slowness
por: Miyawaki, Edison K.
Publicado: (2022)

Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes
por: Shigekiyo, Taro, et al.
Publicado: (2020)

The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review
por: Suwijn, Sven R, et al.
Publicado: (2015)

What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?
por: Nishijima, Haruo, et al.
Publicado: (2016)

Interpreting ciliopathy-associated missense variants of uncertain significance (VUS) in Caenorhabditis elegans
por: Lange, Karen I, et al.
Publicado: (2021)

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
por: Cilia, Roberto, et al.
Publicado: (2011)

[(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2022)

The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans
por: Vlaar, Annemarie MM, et al.
Publicado: (2008)

30-Month Results of Foetal Dopamine Cell Transplantation into the Brains of Parkinsonian Patients
por: Dymecki, J., et al.
Publicado: (1992)

Impairment of Macroautophagy in Dopamine Neurons Has Opposing Effects on Parkinsonian Pathology and Behavior
por: Hunn, Benjamin H.M., et al.
Publicado: (2019)

Rit2 silencing in dopamine neurons drives a progressive Parkinsonian phenotype
por: Kearney, Patrick J., et al.
Publicado: (2023)

Multi-Modal Synergistic 99mTc-TRODAT-1 SPECT and MRI for Evaluation of the Efficacy of Hyperbaric Oxygen Therapy in CO-Induced Delayed Parkinsonian and Non-Parkinsonian Syndromes
por: Yeh, Skye Hsin-Hsien, et al.
Publicado: (2022)

Correction: [(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2023)

The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)

Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of (123)I-Ioflupane SPECT: an investigation of parkinsonian syndromes
por: Iwabuchi, Yu, et al.
Publicado: (2019)

Comparison of perfusion (18)F-FP-CIT PET and (99m)Tc-ECD SPECT in parkinsonian disorders
por: Chun, KyungAh, et al.
Publicado: (2021)

Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients
por: Katthagen, Teresa, et al.
Publicado: (2020)

Neural correlates of standing imagery and execution in Parkinsonian patients: The relevance to striatal dopamine dysfunction
por: Mori, Yutaro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_23vlcersug4igl89evcfvcm8oo